Ironwood Pharmaceuticals
IRWD
#6947
Rank
A$0.85 B
Marketcap
A$5.24
Share price
-6.70%
Change (1 day)
1.17%
Change (1 year)

Earnings for Ironwood Pharmaceuticals (IRWD)

Earnings in 2025 (TTM): A$0.14 Billion

According to Ironwood Pharmaceuticals 's latest financial reports the company's current earnings are A$0.33 Billion. In 2024 the company made an earning of A$98.15 Million, an increase over its 2023 earnings that were of -A$1.43 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ironwood Pharmaceuticals from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$0.14 B43.5%
2024 A$98.15 M-106.88%
2023 -A$1.43 Billion-475.59%
2022 A$0.38 B25.8%
2021 A$0.30 B84.32%
2020 A$0.16 B84.69%
2019 A$88.73 M-125.13%
2018 -A$0.36 Billion100.62%
2017 -A$0.18 Billion43.12%
2016 -A$0.13 Billion-42.73%
2015 -A$0.22 Billion-24.76%
2014 -A$0.29 Billion-30.49%
2013 -A$0.42 Billion275.65%
2012 -A$0.11 Billion11.56%
2011 -A$98.01 Million9.38%
2010 -A$89.6 Million-15.21%
2009 -A$0.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nektar Therapeutics
NKTR
-A$0.18 Billion-221.61%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$19.70 B 13,890.27%๐Ÿ‡ฌ๐Ÿ‡ง UK